| 29th May 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 29th May 2020 4:35 pm |
RNS |
Price Monitoring Extension |
| 29th May 2020 1:00 pm |
RNS |
Imfinzi sustained overall survival in CASPIAN |
| 29th May 2020 1:00 pm |
RNS |
Enhertu DESTINY-Gastric01 results from ASCO 2020 |
| 29th May 2020 7:00 am |
RNS |
Tagrisso unprecedented adjuvant lung cancer data |
| 26th May 2020 10:30 am |
RNS |
Director/PDMR Shareholding |
| 22nd May 2020 7:00 am |
RNS |
Enhertu US orphan designation in gastric cancer |
| 21st May 2020 7:00 am |
RNS |
AstraZeneca advances response to COVID-19 outbreak |
| 20th May 2020 7:00 am |
RNS |
Lynparza approved in the US for prostate cancer |
| 18th May 2020 7:00 am |
RNS |
Enhertu US Breakthrough status for lung cancer |
| 18th May 2020 7:00 am |
RNS |
Bevespi Aerosphere approved in China for COPD |
| 11th May 2020 7:00 am |
RNS |
Enhertu designated gastric cancer BTD |
| 11th May 2020 7:00 am |
RNS |
Lynparza gets broader US ovarian cancer approval |
| 11th May 2020 7:00 am |
RNS |
Brazikumab rights recovered by AstraZeneca |
| 6th May 2020 7:00 am |
RNS |
Farxiga approved by FDA for heart failure (HFrEF) |
| 1st May 2020 3:00 pm |
RNS |
Total Voting Rights |
| 29th Apr 2020 4:00 pm |
RNS |
Result of AGM |
| 29th Apr 2020 7:00 am |
RNS |
AZN: first-quarter 2020 results |
| 24th Apr 2020 7:00 am |
RNS |
Lynparza shows overall survival in prostate cancer |
| 17th Apr 2020 11:00 am |
RNS |
Changes to arrangements for AGM |
| 14th Apr 2020 7:00 am |
RNS |
Koselugo (selumetinib) approved in the US for NF1 |
| 14th Apr 2020 7:00 am |
RNS |
Tagrisso adjuvant trial overwhelmingly positive |
| 2nd Apr 2020 7:00 am |
RNS |
AstraZeneca divestment of Movantik completed |
| 1st Apr 2020 3:00 pm |
RNS |
Total Voting Rights |
| 31st Mar 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 30th Mar 2020 7:01 am |
RNS |
Imfinzi approved in US for small cell lung cancer |
| 30th Mar 2020 7:00 am |
RNS |
Farxiga CKD trial early stop for positive efficacy |
| 26th Mar 2020 7:00 am |
RNS |
Lokelma approved in Japan for hyperkalaemia |
| 26th Mar 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 24th Mar 2020 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 24th Mar 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 24th Mar 2020 12:02 pm |
RNS |
Price Monitoring Extension |
| 23rd Mar 2020 4:40 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Mar 2020 4:36 pm |
RNS |
Price Monitoring Extension |
| 23rd Mar 2020 12:08 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Mar 2020 12:03 pm |
RNS |
Price Monitoring Extension |
| 20th Mar 2020 10:20 am |
RNS |
Second Price Monitoring Extn |
| 20th Mar 2020 10:15 am |
RNS |
Price Monitoring Extension |
| 20th Mar 2020 7:00 am |
RNS |
Director/PDMR Shareholding |
| 19th Mar 2020 7:00 am |
RNS |
Lynparza granted orphan drug designation in Japan |
